Crystal structure of SARS-CoV-2 papain-like protease

Gao, Xiaopan, Qin, Bo, Chen, Pu, Zhu, Kaixiang, Hou, Pengjiao, Wojdyla, Justyna Aleksandra, Wang, Meitian, Cui, Sheng·2021·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2020.08.014

Cited by (339)

Items 101–200 of 339

  1. Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulation
    Farzin Sohraby, Hassan Aryapour · 2021 · PLoS ONE
  2. Host and Viral Zinc-Finger Proteins in COVID-19
    Sabrina Esposito, Gianluca D’Abrosca, Anna Antolak, Paolo V. Pedone, Carla Isernia, Gaetano Malgieri · 2022 · International Journal of Molecular Sciences
  3. Large-Scale Virtual Screening for the Discovery of SARS-CoV‑2 Papain-like Protease (PLpro) Non-covalent Inhibitors
    Olivia Garland, Anh‐Tien Ton, Shoeib Moradi, Jason R. Smith, Suzana Kovacic, Kurtis Ng, Mohit Kumar Pandey, Fuqiang Ban, Jaeyong Lee, Marija Vuckovic et al. · 2023 · Journal of Chemical Information and Modeling
  4. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates
    Mateus Sá Magalhães Serafim, Jadson Castro Gertrudes, Débora Maria Abrantes Costa, Patrícia Rufino Oliveira, Vinícius Gonçalves Maltarollo, Kathia Maria Honorio · 2021 · Bioscience Reports
  5. The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets
    Jianli Ma, Yuwei Deng, Minghui Zhang, Jinming Yu · 2022 · Virulence
  6. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
    G. M. Ferreira, Thanigaimalai Pillaiyar, M. Hirata, A. Poso, Thales Kronenberger · 2022 · Scientific Reports
  7. Potential targets of severe acute respiratory syndrome coronavirus 2 of clinical drug fluvoxamine: Docking and molecular dynamics studies to elucidate viral action
    Saroj Kumar Panda, Parth Sarthi Sen Gupta, Malay Kumar Rana · 2022 · Cell Biochemistry and Function
  8. Polyphenolic Compounds Isolated from Marine Algae Attenuate the Replication of SARS-CoV-2 in the Host Cell through a Multi-Target Approach of 3CLpro and PLpro
    D. P. Nagahawatta, Nisansala Madushani Liyanage, Jun-Geon Je, H.H.A.C.K. Jayawardhana, Thilina Uduwaka Jayawardena, Seong-Hun Jeong, Hyung‐Jun Kwon, Cheol Soo Choi, You‐Jin Jeon · 2022 · Marine Drugs
  9. Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease
    Qian Wang, Guofeng Chen, Jian He, Jiameng Li, Muya Xiong, Haixia Su, Minjun Li, Hangchen Hu, Yechun Xu · 2023 · International Journal of Molecular Sciences
  10. In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors
    Samia A. Elseginy, Manal M. Anwar · 2021 · RSC Advances
  11. In Silico Screening of Plant-Derived Anti-virals from Shorea hemsleyana (King) King ex Foxw Against SARS CoV-2 Main Protease
    DSNBK Prasanth, Gagandeep Singh, Siva Prasad Panda, Suneetha Achanti, Hemant Soni, Tapan K. Chaudhuri, Harshal Ashok Pawar, Md Jahasultana · 2022 · Chemistry Africa
  12. A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2
    Karen Sargsyan, Karine Mazmanian, Carmay Lim · 2023 · Scientific Reports
  13. Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antivirals
    Juliana C. Ferreira, Adrian J. Villanueva, Kenana Al Adem, Samar Fadl, Lara Alzyoud, Mohammad A. Ghattas, Wael M. Rabeh · 2024 · Journal of Biological Chemistry
  14. Inhibitory activities of alginate phosphate and sulfate derivatives against SARS-CoV-2 in vitro
    Cheng Long Yang, Dan Li, Shixin Wang, Meijie Xu, Dingfu Wang, Xin Li, Ximing Xu, Chunxia Li · 2022 · International Journal of Biological Macromolecules
  15. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure–activity relationships
    Lukáš Kerti, Vladimı́r Frecer · 2024 · Bioorganic & Medicinal Chemistry
  16. Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
    Marcel Arruda Diogo, Augusto Gomes Teixeira Cabral, Renata Barbosa de Oliveira · 2024 · Pathogens
  17. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
    Hong Zhou, Wei‐Jian Ni, Wei Huang, Zhen Wang, Ming Cai, Yan-Cai Sun · 2022 · Frontiers in Immunology
  18. SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
    P. V. Ershov, Evgeniy O. Yablokov, Yuri V. Mezentsev, Gennady N. Chuev, Marina V. Fedotova, Sergey E. Kruchinin, Alexis S. Ivanov · 2022 · BIOPHYSICS
  19. β-Cyclodextrins as affordable antivirals to treat coronavirus infection
    Dàlia Raïch Regué, Raquel Tenorio, Isabel Fernández de Castro, Ferran Tarrés-Freixas, Martin Sachse, Daniel Perez‐Zsolt, Jordana Muñoz‐Basagoiti, Sara Y. Fernández-Sánchez, Marçal Gallemí, Paula Ortega-González et al. · 2023 · Biomedicine & Pharmacotherapy
  20. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease
    Roxanna Hajbabaie, Matthew Thomas Harper, Taufiq Rahman · 2021 · Molecules
  21. DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design
    Yang Liu, Jianhong Gan, Rongqi Wang, Xiaocong Yang, Zhi‐Xiong Jim Xiao, Yang Cao · 2022 · Molecules
  22. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
    K. Watashi · 2020 · Biochemical and Biophysical Research Communications - BBRC
  23. Druggable targets and therapeutic development for COVID-19
    Xiaohua Duan, Lauretta A. Lacko, Shuibing Chen · 2022 · Frontiers in Chemistry
  24. Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 MPro and PLPro
    Bhavita Kattula, Bharati Reddi, Aruna Jangam, Lekhika Naik, Bala Manikantha Adimoolam, V. Suresh, Sayanna Are, Jagadeshwar Reddy Thota, Surender Singh Jadav, Mohammed Arifuddin et al. · 2023 · International Journal of Biological Macromolecules
  25. SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads
    Arun Kumar Ghosh, Dana Shahabi, Mackenzie E.C. Imhoff, Satish Kovela, Ashish Sharma, Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hiroaki Mitsuya, Andrew D. Mesecar · 2023 · Bioorganic & Medicinal Chemistry Letters
  26. Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19
    Yang Li, Si-Ming Lu, Jia-Long Wang, Hangping Yao, L. Liang · 2024 · Heliyon
  27. Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme
    Ann Varghese, Jie Liu, Bailang Liu, Wenjing Guo, Fan Dong, Tucker A. Patterson, Huixiao Hong · 2025 · Molecules
  28. Losartan Inhibits SARS-CoV-2 Replication in Vitro
    Reza Nejat, Ahmad Shahir Sadr, Brendan T. Freitas, Jackelyn M. Crabtree, Scott D. Pegan, Ralph A. Tripp, David J. Najafi · 2021 · Journal of Pharmacy & Pharmaceutical Sciences
  29. Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2
    Muhammad Salman Waqas, Saeed Mahmud Ullah, Sobia Ahsan Halim, Najeeb Ur Rehman, Amjad Ali, Afnan Jan, Abdullatif Bin Muhsinah, Ajmal Khan, Ahmed Al‐Harrasi · 2023 · International Journal of Biological Macromolecules
  30. Andrographis paniculata (Burm. F.) Wall. Ex Nees, Andrographolide, and Andrographolide Analogues as SARS-CoV-2 Antivirals? A Rapid Review
    Xin Yi Lim, Janice Sue Wen Chan, Terence Yew Chin Tan, Bee Ping Teh, Mohd Ridzuan Mohd Abd Razak, Saharuddin Bin Mohamad, Ami Fazlin Syed Mohamed · 2021 · Natural Product Communications
  31. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations
    Arwansyah Arwansyah, Abdur Rahman Arif, Irwan Ramli, Isman Kurniawan, Sukarti Sukarti, Masqudul Alam, Ilmiati Illing, A. Farid Lewa, Baso Manguntungi · 2021 · SAR and QSAR in environmental research
  32. Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases
    Anoop Narayanan, Shay A. Toner, Joyce Jose · 2021 · Biochemical Society Transactions
  33. In silico study to identify novel potential thiadiazole-based molecules as anti-Covid-19 candidates by hierarchical virtual screening and molecular dynamics simulations
    Huda R. M. Rashdan, Aboubakr Haredi Abdelmonsef · 2022 · Structural Chemistry
  34. Computational approaches to define poncirin fromMagnolia champakaleaves as a novel multi-target inhibitor of SARS-CoV-2
    Shashank M. Patil, Bhaskar Phanindra, Prithvi S. Shirahatti, Reshma Mary Martiz, Harshit Sajal, Abdullatif Taha Babakr, Ramith Ramu · 2023 · Journal of Biomolecular Structure and Dynamics
  35. Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease
    Wandong Liu, Juan Wang, Suyun Wang, Kairui Yue, Yu Hu, Xiaochun Liu, Lihao Wang, Shengbiao Wan, Ximing Xu · 2023 · Bioorganic Chemistry
  36. Integrating Molecular Dynamics, Molecular Docking, and Machine Learning for Predicting SARS-CoV-2 Papain-like Protease Binders
    Ann Varghese, Jie Liu, Tucker A. Patterson, Huixiao Hong · 2025 · Molecules
  37. Integrative Multi-Omics Landscape of Non-Structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses
    Ruona Shi, Zhenhuan Feng, Xiaofei Zhang · 2021 · Genomics Proteomics & Bioinformatics
  38. Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition
    Julia J. Liang, Eleni Pitsillou, Katherine Ververis, Vı́ctor Guallar, Andrew Hung, Tom C. Karagiannis · 2021 · Chemical Physics Letters
  39. Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine
    Kaitlin R. Hulce, Priyadarshini Jaishankar, Gregory Lee, Markus‐Frederik Bohn, Emily J. Connelly, Kristin Wucherer, Chayanid Ongpipattanakul, Regan F. Volk, Shih‐Wei Chuo, Michelle R. Arkin et al. · 2022 · Cell chemical biology
  40. Covalent Inhibitors from Saudi Medicinal Plants Target RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2
    Ahmed H.H. Bakheit, Quaiser Saquib, Sarfaraz Ahmed, Sabiha Mahmood Ansari, Abdullah M. Al-Salem, Abdulaziz Ali Al-Khedhairy · 2023 · Viruses
  41. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2
    Luana Niederauer Oliveira Leal da Cunha, Tiago Tizziani, Gabriella B. Souza, Monalisa A. Moreira, José S. S. Neto, Carlos V. D. Dos Santos, Maryelle G. de Carvalho, Eduardo Monguilhott Dalmarco, Leonardo B. Turqueti, Luciana Scotti et al. · 2021 · Current Medicinal Chemistry
  42. Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease
    Wei Wei, Ni Kong, Meng-Zhen Liu, Ting Han, Junfeng Xu, Chong Liu · 2022 · Biochemical and Biophysical Research Communications
  43. A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors
    Haohao Yan, Zhicheng Liu, Gangan Yan, Xiaoli Liu, Xiaoping Liu, Yanchang Wang, Yunyu Chen · 2022 · Virology
  44. Bioactive peptides as functional food ingredients: Production, mechanisms of action, market trends, and future perspectives with emphasis on andean crops
    Gabriela Ibieta, Jimena Ortiz-Sempértegui, José Mauricio Peñarrieta, Javier A. Linares‐Pastén · 2025 · Journal of Functional Foods
  45. Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets
    Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura · 2023 · Expert Opinion on Drug Discovery
  46. Benchmarking biomolecular force fields for molecular dynamics simulations of native fold and enzymatic activity of SARS-CoV-2 papain-like protease
    Kateryna O. Lohachova, Alexander V. Kyrychenko, Oleg N. Kalugin · 2025 · Heliyon
  47. Unraveling the Molecular Mechanism of Recognition of Human Interferon-Stimulated Gene Product 15 by Coronavirus Papain-Like Proteases: A Multiscale Simulation Study
    Rajarshi Roy, Nisha Amarnath Jonniya, Sayan Poddar, Md Fulbabu Sk, Parimal Kar · 2021 · Journal of Chemical Information and Modeling
  48. Investigation of changes in protein stability and substrate affinity of 3CL-protease of SARS-CoV-2 caused by mutations
    Ekrem Akbulut · 2022 · Genetics and Molecular Biology
  49. Effects of diarylbutane lignans from Schisandra chinensis fruit on SARS-CoV-2 3CLpro and PLpro and their in vitro anti-inflammatory properties
    Bin Li, Liansheng Qiao, Qi Xiao, Jianuo Zhang, Jiushi Liu, Bengang Zhang, Haitao Liu · 2023 · Phytomedicine Plus
  50. Structural insights into SARS-CoV-2 infection and therapeutics development
    Gangyu Sun, Lulu Xue, Qingjing He, Yue Zhao, Wenqing Xu, Zhizhi Wang · 2021 · Stem Cell Research
  51. Chemical Space Profiling of SARS-CoV-2 PL pro Using DNA-Encoded Focused Libraries
    Xudong Wang, Ying Zhu, Qingyi Zhao, Weiwei Lu, Yechun Xu, Hangchen Hu, Xiaojie Lu · 2024 · ACS Medicinal Chemistry Letters
  52. Boosting immunity: synergistic antiviral effects of luteolin, vitamin C, magnesium and zinc against SARS-CoV-2 3CLpro
    Juliana C. Ferreira, Samar Fadl, Thyago Hermylly Santana Cardoso, Bruno Silva Andrade, Tarcísio Silva Melo, Edson Mário de Andrade Silva, Anupriya Agarwal, Stuart Grant Turville, Nitin K. Saksena, Wael M. Rabeh · 2024 · Bioscience Reports
  53. In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides
    Mohammad Moradi, Reza Golmohammadi, Ali Najafi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi‐Ramandi, Reza Mirnejad · 2021 · International Journal of Peptide Research and Therapeutics
  54. Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease
    Cécilia Hognon, Marco Marazzi, Cristina García‐Iriepa · 2022 · International Journal of Molecular Sciences
  55. Therapeutic potential of metal ions for COVID-19: insights from the papain-like protease of SARS-CoV-2
    Cameron Lee Shetler, Juliana C. Ferreira, Thyago Hermylly Santana Cardoso, Edson M.A. Silva, Nitin K. Saksena, Wael M. Rabeh · 2022 · Biochemical Journal
  56. Biosensors based detection of novel biomarkers associated with COVID-19: Current progress and future promise
    Mintu Pal, Thingreila Muinao, Arpana Parihar, Dilip Kumar Roy, Hari Prasanna Deka Boruah, Neeraj Mahindroo, Raju Khan · 2022 · Biosensors and Bioelectronics X
  57. Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
    Teena Bajaj, Eddie Wehri, Rahul K. Suryawanshi, Elizabeth King, Kundansingh A. Pardeshi, Kamyar Behrouzi, Zahra Khodabakhshi, Ursula Schulze‐Gahmen, G. Renuka Kumar, Mohammad R. K. Mofrad et al. · 2023 · RSC Advances
  58. NMR Characterization of the Papain-like Protease from SARS-CoV-2 Identifies the Conformational Heterogeneity in Its Inhibitor-Binding Site
    Yutaro Shiraishi, Ichio Shimada · 2023 · Journal of the American Chemical Society
  59. Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
    Pei-Chen Yu, Chen-Hao Huang, Chih‐Jung Kuo, Po‐Huang Liang, Lily Hui-Ching Wang, Max Yu-Chen Pan, Sui‐Yuan Chang, Tai‐Ling Chao, Si‐Man Ieong, Jun‐Tung Fang et al. · 2022 · Pharmaceutics
  60. SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites
    Kaixiang Zhu, Lili Song, Linyue Wang, Lei Hua, Zi-Yu Luo, Tong-Yun Wang, Bo Qin, Shuofeng Yuan, Xiaopan Gao, Wenyi Mi et al. · 2024 · Acta Pharmaceutica Sinica B
  61. Design, Synthesis, and Biological Evaluation of 1,2,4-Oxadiazole Derivatives Containing an Aryl Carboxylic Acid Moiety as Potent Sarbecovirus Papain-like Protease Inhibitors
    Bo Qin, Chengwei Wu, Binbin Zhao, Gang Li, Baolian Wang, Mengdie Ou, Ziheng Li, Xuli Lang, Peng Li, Jiangning Liu et al. · 2024 · Journal of Medicinal Chemistry
  62. Pathfinder-Driven Chemical Space Exploration and Multiparameter Optimization in Tandem with Glide/IFD and QSAR-Based Active Learning Approach to Prioritize Design Ideas for FEP+ Calculations of SARS-CoV-2 PLpro Inhibitors
    Njabulo Joyfull Gumede · 2022 · Molecules
  63. Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19
    Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene Bernadette Khan, Hezekiel Mathambo Kumalo · 2024 · BioChem
  64. Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking
    Sergio Román Ribone, S. Alexis Paz, Cameron F. Abrams, Marcos Ariel Villarreal · 2021 · Journal of Computer-Aided Molecular Design
  65. An outlook on potential protein targets of COVID-19 as a druggable site
    Rubia Noori, Meryam Sardar · 2022 · Molecular Biology Reports
  66. Molecular modeling of lupeol for antiviral activity and cellular effects
    Pawi Bawitlung Lalthanpuii, C. Lalrinmawia, B. Lalruatfela, Lal Ramliana, Kholhring Lalchhandama · 2023 · Journal of Applied Pharmaceutical Science
  67. A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibition
    Katrina L. Forrestall, Eric S. Pringle, Dane C. Sands, Brett A. Duguay, Brett Farewell, Tekeleselassie Ayalew Woldemariam, Darryl Falzarano, Ian R. Pottie, Craig McCormick, Sultan Darvesh · 2023 · Antiviral Research
  68. Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies
    Eleni Pitsillou, Julia J. Liang, Andrew Hung, Tom C. Karagiannis · 2021 · Chemical Physics Letters
  69. The Swiss army knife of SARS-CoV-2: the structures and functions of NSP3
    Lea C. von Soosten, Maximilian Edich, Kristopher Nolte, Johannes Kaub, Gianluca Santoni, Andrea Thorn · 2022 · Crystallography Reviews
  70. Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease
    Huarui Qiao, Lingyun Li, Lu Wang, Haijun Yu, Fangzheng Hu, Xin Zhou, Hongzhao Yang, Jianfeng Xu, Xiangjing Meng, Yong Geng et al. · 2023 · Protein Expression and Purification
  71. Searching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets
    Joyce S. F. D. de Almeida, Fernanda D. Botelho, Felipe Rodrigues de Souza, Marcelo Carneiro dos Santos, Arlan da Silva Gonçalves, Rodrigo Leonard Barboza Rodrigues, Monique Cardozo, Daniel A. S. Kitagawa, Leandro A. Vieira, Raphael S. F. Silva et al. · 2021 · Journal of Biomolecular Structure and Dynamics
  72. Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2
    Brian Sanders, Suman Pokhrel, Audrey D. Labbe, Irimpan I. Mathews, Connor J. Cooper, Russell B. Davidson, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Hugh O’Neill et al. · 2022 · Research Square
  73. Review of the crystallized structures of the SARS-CoV-2 papain-like protease
    Yue Qiu, Jiang Hua-Juan, Yu‐Shun Yang, Xiaoqin Hu, Zeng Xue-Wen · 2025 · Journal of Molecular Structure
  74. Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2
    Shilpa Sharma, Ashish Sharma, Dipto Bhattacharyya, Rajinder Singh Chauhan · 2021 · Journal of Biomolecular Structure and Dynamics
  75. Harnessing and bioprospecting botanical-based herbal medicines against potential drug targets for COVID-19: a review coupled molecular docking studies
    Tarun Pal, Uttpal Anand, Shreya Sikdar Mitra, Protha Biswas, Vijay Shankar Tripathi, Jarosław Proćków, Abhijit Dey, José Manuel Pérez de la Lastra · 2023 · Journal of Biomolecular Structure and Dynamics
  76. Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies
    Quaiser Saquib, Ahmed H.H. Bakheit, Sarfaraz Ahmed, Sabiha Mahmood Ansari, Abdullah M. Al-Salem, Abdulaziz Ali Al-Khedhairy · 2024 · Molecules
  77. Myrtucommulones and Related Acylphloroglucinols from Myrtaceae as a Promising Source of Multitarget SARS-CoV-2 Cycle Inhibitors
    Simony Carvalho Mendonça, Brendo Araújo Gomes, Mariana Freire Campos, Thamirys Silva da Fonseca, Maria Eduarda Alves Esteves, Bruce Veiga Andriolo, Caio Felipe de Araujo Ribas Cheohen, Larissa Esteves Carvalho Constant, Stephany da Silva Costa, Pedro Telles Calil et al. · 2024 · Pharmaceuticals
  78. Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2
    Deepesh Kumar Patel, Harish Kumar, Masilamani Elizabeth Sobhia · 2024 · Computational Biology and Chemistry
  79. Mechanistic Insights into Nitrile and Alkyne Covalent Inhibitors of the SARS-CoV-2 Main Protease
    Ashim Nandi, Mojgan Asadi, Aoxuan Zhang, Zhen Tao Chu, Arieh Warshel · 2025 · ACS Catalysis
  80. SARS-CoV-2 Papain-like Protease Negatively Regulates the NLRP3 Inflammasome Pathway and Pyroptosis by Reducing the Oligomerization and Ubiquitination of ASC
    Huan Meng, Jianglin Zhou, Mingyu Wang, Mei Zheng, Yaling Xing, Yajie Wang · 2023 · Microorganisms
  81. Hydrogen bonding penalty used for virtual screening to discover potent inhibitors for Papain‐Like cysteine proteases of SARS‐CoV‐2
    Guangjian Zhao, Xiaochun Liu, Suyun Wang, Zhongyue Bai, Siyu Zhang, Yifan Wang, Haibo B. Yu, Ximing Xu · 2022 · Chemical Biology & Drug Design
  82. Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and have utility for substrate identification
    Lennart Brewitz, H. T. Henry Chan, Petra Lukacik, Claire M. Strain-Damerell, Martin Austin Walsh, Fernanda Duarte, Christopher John Schofield · 2023 · Bioorganic & Medicinal Chemistry
  83. Identification of Naturally Occurring Antiviral Molecules for SARS-CoV-2 Mitigation
    Shiwani Rana, Prateek Kumar, Anchal Sharma, Sanjay Kumar Sharma, Rajanish Giri, Kalyan Sundar Ghosh · 2021 · The Open COVID Journal
  84. New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs
    Wenyi Zhang, Lecheng Xiao, Dianyang Li, Yuxuan Hu, Wenying Yu · 2024 · Journal of Medicinal Chemistry
  85. Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches
    Muhammad Salman Waqas, Saeed Mahmud Ullah, Atta Ullah, Sobia Ahsan Halim, Najeeb Ur Rehman, Asaad Khalid, Amjad Ali, Ajmal Khan, Simon Gibbons, René Csük et al. · 2024 · International Journal of Biological Macromolecules
  86. Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease
    Zhihui Zou, Huizhuang Shan, Demeng Sun, Xia Li, Yulong Shi, Jiahui Wan, Aiwu Zhou, Yunzhao Wu, Hanzhang Xu, Hu Lei et al. · 2022 · Acta Biochimica et Biophysica Sinica
  87. Search for Novel Potent Inhibitors of the SARS-CoV-2 Papain-like Enzyme: A Computational Biochemistry Approach
    Manuel Isaías Osorio, Osvaldo Yáñez, Mauricio O. Gallardo, Matías Zúñiga-Bustos, Jorge Mulia-Rodríguez, Roberto López-Rendón, Olimpo García‐Beltrán, Fernando Danilo González-Nilo, Jose Manuel Perez-Donoso · 2022 · Pharmaceuticals
  88. Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
    Yue Qiu, Qing Liu, Gao Tu, Xiaojun Yao · 2022 · International Journal of Molecular Sciences
  89. Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19
    Sundaresan Bhavaniramya, Vanajothi Ramar, Selvaraju Vishnupriya, Palaniappan Ramasamy, Ashokkumar Sibiya, Baskaralingam Vaseeharan · 2021 · Current Molecular Pharmacology
  90. Activity profiling of deubiquitinating inhibitors-bound to SARS-CoV-2 papain like protease with antiviral efficacy in murine infection model
    Shweta Choudhary, Sanketkumar Nehul, Santhosh Kambaiah Nagaraj, Rohan Narayan, Shalja Verma, Swati Sharma, Annu Kumari, Ruchi Rani, Ankita Saha, Debabrata Sircar et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro
    Igor Andrade Santos, Victória Riquena Grosche, Natasha Marques Cassani, Rodrigo Cássio Sola Veneziani, Gustavo Lima Ribeiro, Jairo Kenupp Bastos, Nilson Nicolau-Júnior, Andres Merits, Carlos Henrique Gomes Martins, Mark Harris et al. · 2025 · Frontiers in Microbiology
  92. Computational Study on SARS-CoV-2 Viral Protein Interaction with Natural Compounds of Coriandrum sativum L
    Roshan Priyarangana Perera, S. P. B. M Senadheera, Suresh Hewapathirana · 2022 · International Conference on Advanced Research in Computing (ICARC)
  93. SARS-CoV-2 and UPS with potentials for therapeutic interventions
    Jannatul Ferdoush, Rizwaan Abdul Kadir, Selin Kaplanoğlu, Morgan Osborn · 2024 · Gene
  94. Plants Metabolites as In Vitro Inhibitors of SARS-CoV-2 Targets: A Systematic Review and Computational Analysis
    Brendo Araújo Gomes, Diégina Araújo Fernandes, Thamirys Silva da Fonseca, Mariana Freire Campos, Patrícia Alves Jural, Marcos Vinicius Toledo e Silva, Larissa Esteves Carvalho Constant, Andrex Augusto Silva da Veiga, Beatriz Ribeiro Ferreira, Ellen Santos Magalhães et al. · 2025 · Drugs and Drug Candidates
  95. Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics
    Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Petra Krafčíková, Evžen Bouřa, Murali Aarthy, Muthuraja Arun Pravin, Sanjeev Kumar Singh · 2021 · Current Molecular Pharmacology
  96. Production of recombinant SARS-CoV-2 3CL-protease: The key for the development of protease inhibitors screening kit in search of potential herb cure for COVID-19
    Haniyya Haniyya, Maria Ulfah, Asep Riswoko, Lina Mulyawati, Teni Ernawati, Is Helianti · 2022 · IOP Conference Series Earth and Environmental Science
  97. Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
    Martynas Bagdonas, Kamilė Čerepenkaitė, Aurelija Mickevičiu̅tė, Rūta Kananavičiūtė, Birutė Grybaitė, Kazimieras Anusevičius, Audronė Rukšėnaitė, Tautvydas Kojis, Marius Gedgaudas, Vytautas Mickevičius et al. · 2023 · International Journal of Molecular Sciences
  98. Alkaloids and Alkaloid-Like Compounds are Potential Scaffolds of Antiviral Agents against SARS-CoV-2 (COVID-19) Virus
    Prasat Kittakoop, Dhanushka Darshana, Rapeepat Sangsuwan, Chulabhorn Mahidol · 2022 · Heterocycles
  99. Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors
    Haitham Hassan, Jeanne Chiavaralli, Afnan Hassan, Loay Bedda, Tim Krischuns, Kuang‐Yu Chen, Alice Shi Ming Li, Adrien Delpal, Étienne Decroly, Masoud Vedadi et al. · 2023 · RSC Medicinal Chemistry
  100. Research progress on critical viral protease inhibitors for coronaviruses and enteroviruses
    Shulei Hu, Qiuyu Zhong, Xiong Xie, Shurui Zhang, Jinlin Wang, Hong Shu Liu, Wenhao Dai · 2025 · Bioorganic & Medicinal Chemistry Letters